Chronic graft-versus-host disease complicated by acute hepatitis B

被引:1
作者
Chiba, T
Yokosuka, O
Kojima, H
Fukai, K
Imazeki, F
Saisho, H
Nishimura, M
Saito, Y
机构
[1] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba 2608670, Japan
[2] Chiba Univ, Grad Sch Med, Med Genome Res & Clin Applicat, Chiba 2608670, Japan
关键词
BMT; GVHD; HBV; acute hepatitis;
D O I
10.1097/00004836-200302000-00018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We observed a 45-year-old man with acute hepatitis B while receiving treatment of chronic graft-versus-host disease (GVHD) of the liver. When he developed a sudden elevation of serum aminotransferases 17 months after bone marrow transplantation, he was under immunosuppressive therapy consisting of cyclosporin A against chronic GVHD of the liver. Serologic tests for hepatitis B virus (HBV) showed no reactivation but de novo acute infection. The serum levels of aminotransferases after elevation of biliary tract enzymes increased mildly. However, icterus was not observed in his sequential course. A liver biopsy specimen revealed mild acute liver injury accompanied by slight degeneration of bile ducts. It is presumed that owing to immunosuppressive therapy, his liver dysfunction was relatively mild, and the hepatitis became quiescent without becoming serious. On the other hand, the serum of the patient remained hepatitis B surface antigen positive for more than 1 year after the onset of the hepatitis, which suggested chronicity of HBV infection.
引用
收藏
页码:179 / 181
页数:3
相关论文
共 50 条
  • [1] Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid
    Chiba, T
    Yokosuka, O
    Kanda, T
    Fukai, K
    Imazeki, F
    Saisho, H
    Nishimura, M
    Saito, Y
    LIVER, 2002, 22 (06): : 514 - 517
  • [2] CNS manifestations in acute and chronic graft-versus-host disease
    Lambert, Nicolas
    Forte, Florence
    El Moussaoui, Majdouline
    Monseur, Justine
    Raus, Nicole
    Polushin, Alexey
    Michonneau, David
    Shultz, Carl
    Hogan, William J.
    Balaguer-Rosello, Aitana
    Gil-Perotin, Sara
    Brijs, Jan
    Chauvet, Paul
    Gavriilaki, Maria
    Carre, Martin
    Dulamea, Adriana Octaviana
    Chalandon, Yves
    Salmenniemi, Urpu
    Duminuco, Andrea
    Ram, Ron
    Garcia-Cadenas, Irene
    Porto, Gaetana
    Nguyen, Stephanie
    Smallbone, Portia
    Gonzalez-Vicent, Marta
    Santoro, Jonathan D.
    Willems, Evelyne
    Baron, Frederic
    Servais, Sophie
    Beguin, Yves
    Maquet, Pierre
    CNS GvHD Study Group, Nicolas
    BRAIN, 2025, : 1122 - 1133
  • [3] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
  • [4] Assessing response of therapy for acute and chronic graft-versus-host disease
    Goldberg, Jenna D.
    Giralt, Sergio
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (01) : 103 - 107
  • [5] Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease
    Braun, Lukas M.
    Zeiser, Robert
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [6] Therapy of chronic graft-versus-host disease
    Arora, Mukta
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) : 271 - 279
  • [7] Rehabilitation in Chronic Graft-Versus-Host Disease
    Smith, Sean Robinson
    Asher, Arash
    PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, 2017, 28 (01) : 143 - +
  • [8] Oral acute graft-versus-host disease
    Teymouri, Farzad
    Sebastian, Gale
    Gem, Hakan
    Minot, Samuel S.
    Rashidi, Armin
    EJHAEM, 2024, 5 (06): : 1290 - 1294
  • [9] Pulmonary graft-versus-host disease
    Gadaleta, G
    Angelucci, E
    HAEMATOLOGICA, 2001, 86 (12) : 1322 - 1322
  • [10] Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells
    Ukena, Sya N.
    Geffers, Robert
    Buchholz, Stefanie
    Stadler, Michael
    Franzke, Anke
    TRANSPLANT IMMUNOLOGY, 2012, 27 (04) : 179 - 183